Business / Finance

RSS

InVivo Therapeutics reports net income of $3,150,000 for first quarter 2012

InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported the financial results for the three months ended March 31, 2012 and provided a business update.

15 May 2012

Sinovac first quarter sales increase 30.3% to $6.0M

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter financial results for the period ended March 31, 2012.

15 May 2012

Flexpoint obtains purchase order for disposable colonoscope device

Flexpoint Sensor Systems, Inc., a leader in design and supply of thin film sensing technology, announced today that they have received a purchase order for the a disposable colonoscope device.

15 May 2012

Conmed first quarter net revenue increases 16.1% to $18.9 million

Conmed Healthcare Management, Inc. today announced financial results for its first quarter ended March 31, 2012.

15 May 2012

PDI first quarter revenue decreases 28% to $31.7 million

PDI, Inc., today reported financial and operational results for the first quarter ended March 31, 2012.

15 May 2012

SANUWAVE first quarter revenues decrease 5% to $238,540

SANUWAVE Health, Inc. today reported financial results for the three months ended March 31, 2012 and provided a business update.

15 May 2012

NAI third quarter net sales increase 30.3% to $17.4 million

Natural Alternatives International, Inc., a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $1.1 million or $0.15 per diluted share on net sales of $17.4 million for the quarter ended March 31, 2012.

15 May 2012

IMRIS first quarter revenues decrease to $3.5 million

IMRIS Inc. today reported its results for the first quarter of 2012. All figures are reported in US dollars.

15 May 2012

AxoGen first quarter revenues increase 47% to $1.65 million

AxoGen, Inc., a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced revenues for the first quarter ended March 31, 2012 of $1.65 million, a 47% increase over 2011 first quarter revenues of $1.12 million.

15 May 2012

Conmed signs new contract with Howard County

Conmed Healthcare Management, Inc., a leading full service provider of correctional facility healthcare services to county detention centers, today announced that it has signed an agreement with Howard County, Maryland for an initial one-year term with options for nine one-year extensions, which are at the County's option effective July 1, 2012.

15 May 2012

Accellent first quarter net sales increase 1.3% to $131.6 million

Accellent Inc., a wholly owned subsidiary of Accellent Holdings Corp., today announced results for its fiscal first quarter ended March 31, 2012.

15 May 2012

Electromed third quarter net revenues decrease 8.2% to $4,774,000

Electromed, Inc. today announced financial results for the three-month period ended March 31, 2012.

15 May 2012

MedNPV, SurgLine partner to supply low cost spinal orthopedic implants

Thomas Toland, CEO of SGLN and SurgLine, Inc. announced today it has signed an agreement with MedNPV, LLC, a well-established management company and surgical group operator with business throughout the state of California. The agreement between the parties will permit SurgLine to supply its' low cost spinal orthopedic implants.

14 May 2012

Soligenix first quarter revenues decrease to $647,418

Soligenix, Inc., a development stage biopharmaceutical company, announced today its financial results for the quarter ending March 31, 2012.

14 May 2012

Encision fourth quarter revenue increases to $3.370 million

Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, today announced financial results for its fiscal 2012 fourth quarter and fiscal year ended March 31, 2012.

14 May 2012